Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Oral Immunotherapy for Peanut Allergic Patients — Stella

Home/Peanut Allergy/Oral Immunotherapy for Peanut Allergic Patients

View on ClinicalTrials.gov

Recruiting

Back to Peanut Allergy trials

Oral Immunotherapy for Peanut Allergic Patients

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(2 sites)

Spain

Clinica Universidad de Navarra, Pamplona, Navarre

Complejo Hospittalario de Navarra, Pamplona, Navarre

Key details

Phase

Early testing / Safety & dosing

Sponsor

InnoUp Farma S.L.

Enrollment target

~50 participants

Started

March 2020

Primary completion

May 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

12 Years – 65 Years

Last updated April 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.